Diversified Trust Co Has $4 Million Holdings in McKesson Co. (NYSE:MCK)

Diversified Trust Co lowered its holdings in McKesson Co. (NYSE:MCK - Free Report) by 17.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,015 shares of the company's stock after selling 1,448 shares during the period. Diversified Trust Co's holdings in McKesson were worth $3,998,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA increased its holdings in McKesson by 2.9% in the third quarter. Massachusetts Financial Services Co. MA now owns 4,943,520 shares of the company's stock valued at $2,444,175,000 after buying an additional 138,685 shares during the last quarter. FMR LLC increased its holdings in shares of McKesson by 17.3% in the 3rd quarter. FMR LLC now owns 2,968,239 shares of the company's stock valued at $1,467,557,000 after acquiring an additional 438,423 shares during the last quarter. Geode Capital Management LLC raised its position in shares of McKesson by 1.0% during the 3rd quarter. Geode Capital Management LLC now owns 2,653,288 shares of the company's stock valued at $1,306,873,000 after acquiring an additional 26,299 shares in the last quarter. Legal & General Group Plc lifted its stake in McKesson by 2.9% during the second quarter. Legal & General Group Plc now owns 1,297,620 shares of the company's stock worth $757,862,000 after purchasing an additional 36,583 shares during the last quarter. Finally, The Manufacturers Life Insurance Company boosted its holdings in McKesson by 55.8% in the third quarter. The Manufacturers Life Insurance Company now owns 1,189,377 shares of the company's stock worth $588,048,000 after purchasing an additional 425,875 shares during the period. Institutional investors and hedge funds own 85.07% of the company's stock.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Leann B. Smith sold 579 shares of the firm's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total value of $331,645.41. Following the completion of the transaction, the executive vice president now directly owns 864 shares in the company, valued at $494,890.56. This trade represents a 40.12 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.11% of the stock is owned by corporate insiders.

McKesson Stock Performance

Shares of MCK stock traded up $4.91 during mid-day trading on Tuesday, hitting $585.34. 652,660 shares of the stock traded hands, compared to its average volume of 642,465. The firm has a market cap of $74.30 billion, a price-to-earnings ratio of 30.31, a price-to-earnings-growth ratio of 1.25 and a beta of 0.49. The company's 50-day simple moving average is $586.13 and its 200-day simple moving average is $561.38. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $637.51.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating the consensus estimate of $6.88 by $0.19. The company had revenue of $93.65 billion during the quarter, compared to analyst estimates of $89.33 billion. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. The business's revenue for the quarter was up 21.3% on a year-over-year basis. During the same quarter last year, the firm posted $6.23 EPS. Analysts forecast that McKesson Co. will post 32.73 earnings per share for the current year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Monday, December 2nd were given a $0.71 dividend. The ex-dividend date of this dividend was Monday, December 2nd. This represents a $2.84 annualized dividend and a yield of 0.49%. McKesson's dividend payout ratio (DPR) is 14.71%.

Analyst Ratings Changes

MCK has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft dropped their target price on shares of McKesson from $623.00 to $579.00 and set a "buy" rating on the stock in a report on Wednesday, September 25th. Morgan Stanley increased their price objective on shares of McKesson from $612.00 to $642.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 17th. Leerink Partners decreased their target price on McKesson from $665.00 to $630.00 and set an "outperform" rating for the company in a research note on Monday, October 7th. Wells Fargo & Company increased their price target on McKesson from $535.00 to $641.00 and gave the stock an "equal weight" rating in a research report on Friday, December 13th. Finally, Bank of America lowered their price objective on McKesson from $680.00 to $650.00 and set a "buy" rating for the company in a research note on Monday. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $648.71.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.